Active Pharmaceutical Ingredients (API) Market in the US Driven by Strong Preference for Generic Drugs to Grow at a CAGR of 7% by 2019

The report analyzes and presents an overview on "Active Pharmaceutical Ingredients (API) Market in the US 2015-2019" worldwide.


Albany, NY -- (SBWIRE) -- 10/11/2017 -- Active pharmaceutical ingredients (API) are active substances that are used in the manufacture of drugs and that have pharmacological effects. They provide health benefits and play a vital role in disease diagnosis, prevention, and treatment. API may be synthesized either chemically or through biotechnological methods. They are used in a wide range of therapeutic areas such as oncology and for treatment of conditions such as respiratory disorders and rheumatoid arthritis.

The API market in the US to grow at a CAGR of 7.01 percent over the period 2014-2019.

Get The Sample Copy Of Report:

Covered in this Report

The report covers the present scenario and the growth prospects of the API market in the US for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of API by vendors in the market. It provides the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The market segmentation is carried out on the basis of: type of production process (synthetic production process and biotechnology-based production process), type of product (conventional API and high-potency API), and type of players (captive and merchant).

The report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio's report, the API Market in the US 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts.

Key Vendors

Abbott Laboratories
Aurobindo Pharma
Teva Pharmaceutical Industries

Other Prominent Vendors

Boehringer Ingelheim
Dr. Reddy's Laboratories
Lonza Group
Sun Pharmaceutical Industries

Send An Enquiry:

Market Driver
Strong Preference for Generic Drugs
For a full, detailed list, view our report

Market Challenge
Decrease in R&D Spending
For a full, detailed list, view our report

Market Trend
Strong Focus on High-potency API
For a full, detailed list, view our report

Key Questions Answered in this Report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?